EOM Pharmaceuticals Holdings, Inc. (OTCMKTS:IMUC – Get Free Report) shares traded down 0.1% during trading on Monday . The stock traded as low as $0.17 and last traded at $0.17. 2,063 shares changed hands during mid-day trading, a decline of 31% from the average session volume of 3,009 shares. The stock had previously closed at $0.17.
EOM Pharmaceuticals Price Performance
The stock’s 50 day moving average is $0.16 and its two-hundred day moving average is $0.15.
About EOM Pharmaceuticals
Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis.
Featured Stories
- Five stocks we like better than EOM Pharmaceuticals
- The How and Why of Investing in Gold Stocks
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- What is a buyback in stocks? A comprehensive guide for investors
- 2 Drone Stocks Surging from Increased Media Attention
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for EOM Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EOM Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
